Licensing partners in key Asia Pacific countries have filed for approval of neffy (epinephrine nasal spray) 2 mg with ...

The notion of glycaemic index is not new, and the adoption of drugs to slow the absorption of carbohydrates, most especially using glycoside inhibitors, is currently recognised in diabetes management.

These biofilms act as thick barriers limiting the entry of drugs and helping the bacteria ... In people with diabetes, it infects wounds, which end up healing slowly, leading to complications ...

including that it may reduce the effectiveness of certain medications and is thought to have estrogen-like properties (problematic for those with hormone-related conditions). People with heart ...

Supplements are being recalled because they contain prescription diabetes drugs that could have fatal side effects.

NEW ORLEANS -- Patients at a community health center who had type 2 diabetes and a high risk of atherosclerotic ...

Glucagon-like peptide 1 receptor agonists and fenofibrates may protect patients with type 2 diabetes against diabetic macular ...

On December 10, JD Health, in collaboration with Merck, a globally renowned biopharmaceutical leader, began offering ...

Kumamoto University scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and ...

Of patients who met the high-risk criteria, 55% were not on American Diabetes Association (ADA) guideline-directed medication therapy with an SGLT-2 inhibitor or GLP-1 agonist. In only 34% of ...

People with diabetes may have a lower risk of serious clots with GLP-1 drugs than with some other diabetes medications, a new study finds. People with diabetes may get fewer serious blood clots ...